Pier Capital, LLC Emergent Bio Solutions Inc. Transaction History

Pier Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $3.64 Million - $5.17 Million	-64,274 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $3.92 Million - $5.7 Million	-45,512 Reduced 41.46%	64,274 $5.97 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $2.41 Million - $3.4 Million	30,486 Added 38.44%	109,786 $9.84 Million
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $2.27 Million - $3.74 Million	27,712 Added 53.72%	79,300 $8.19 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $2.28 Million - $3.76 Million	-42,015 Reduced 44.89%	51,588 $4.08 Million
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $413,271 - $575,933	-8,376 Reduced 8.21%	93,603 $5.42 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $1.46 Million - $1.69 Million	-28,594 Reduced 21.9%	101,979 $5.5 Million
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $726,983 - $1.02 Million	-17,906 Reduced 12.06%	130,573 $6.83 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $1.52 Million - $2.05 Million	38,033 Added 34.44%	148,479 $7.17 Million
Q1 2019 Apr 24, 2019	BUY	$48.23 - $66.16 $2.76 Million - $3.79 Million	57,254 Added 107.64%	110,446 $5.58 Million
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $4.44 Million - $5.85 Million	-79,848 Reduced 60.02%	53,192 $3.15 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $6.92 Million - $8.85 Million	133,040 New	133,040 $8.76 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.